1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Hill-Rom

Anonymous board for Hill-Rom


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    19
    Views:
    6,695
  2. anonymous
    Replies:
    1
    Views:
    646
  3. anonymous
    Replies:
    5
    Views:
    2,325
  4. anonymous
    Replies:
    9
    Views:
    2,623
  5. anonymous
    Replies:
    8
    Views:
    3,852
  6. anonymous
    Replies:
    2
    Views:
    1,923
  7. Anonymous
    Replies:
    2,056
    Views:
    619,831
  8. anonymous
    Replies:
    25
    Views:
    11,920
  9. Anonymous
    Replies:
    114
    Views:
    43,504
  10. anonymous
    Replies:
    2
    Views:
    2,055
  11. anonymous
    Replies:
    0
    Views:
    1,259
  12. Anonymous
    Replies:
    8
    Views:
    5,074
  13. anonymous
    Replies:
    19
    Views:
    7,125
  14. anonymous
    Replies:
    0
    Views:
    2,699
  15. anonymous
    Replies:
    3
    Views:
    2,728
  16. Anonymous
    Replies:
    12
    Views:
    9,606
  17. anonymous
    Replies:
    0
    Views:
    1,855
  18. anonymous
    Replies:
    1
    Views:
    2,661
  19. Anonymous
    Replies:
    81
    Views:
    27,173
  20. Anonymous
    Replies:
    19
    Views:
    10,575

Thread Display Options

Loading...